209 related articles for article (PubMed ID: 1311143)
1. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation.
Wada H; Ohiwa M; Kaneko T; Tamaki S; Tanigawa M; Shirakawa S; Koyama M; Hayashi T; Suzuki K
Am J Hematol; 1992 Jan; 39(1):20-4. PubMed ID: 1311143
[TBL] [Abstract][Full Text] [Related]
2. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
[TBL] [Abstract][Full Text] [Related]
4. Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation.
Hori Y; Wada H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Nishii K; Tamaki S; Nishikawa M; Deguchi K; Minami N; Shiku H
Am J Hematol; 1999 May; 61(1):21-5. PubMed ID: 10331507
[TBL] [Abstract][Full Text] [Related]
5. [Thrombomodulin as a clinical marker in thrombotic thrombocytopenic purpura. Japan TTP Study Group].
Hirosawa S; Koyama T
Nihon Rinsho; 1993 Jan; 51(1):129-34. PubMed ID: 8381883
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
Kobayashi M; Wada H; Wakita Y; Shimura M; Nakase T; Hiyoyama K; Nagaya S; Minami N; Nakano T; Shiku H
Thromb Haemost; 1995 Jan; 73(1):10-4. PubMed ID: 7740478
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
Wada H; Kaneko T; Ohiwa M; Tanigawa M; Hayashi T; Tamaki S; Minami N; Deguchi K; Suzuki K; Nakano T
Am J Hematol; 1993 Oct; 44(2):101-5. PubMed ID: 8266913
[TBL] [Abstract][Full Text] [Related]
8. Characteristics Behaviors of Coagulation and Fibrinolysis Markers in Acquired Thrombotic Thrombocytopenic Purpura.
Sakai K; Wada H; Nakatsuka Y; Kubo M; Hayakawa M; Matsumoto M
J Intensive Care Med; 2021 Apr; 36(4):436-442. PubMed ID: 31964209
[TBL] [Abstract][Full Text] [Related]
9. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Mori Y; Wada H; Okugawa Y; Tamaki S; Nakasaki T; Watanabe R; Gabazza EC; Nishikawa M; Minami N; Shiku H
Clin Appl Thromb Hemost; 2001 Jan; 7(1):5-9. PubMed ID: 11190905
[TBL] [Abstract][Full Text] [Related]
11. Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases.
Habe K; Wada H; Ito-Habe N; Hatada T; Matsumoto T; Ohishi K; Maruyama K; Imai H; Mizutani H; Nobori T
Thromb Res; 2012 May; 129(5):598-602. PubMed ID: 22070827
[TBL] [Abstract][Full Text] [Related]
12. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T
Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
[TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation.
Hiyoyama K; Wada H; Shimura M; Nakasaki T; Katayama N; Nishikawa M; Shiku H; Tahara T; Kato T
Blood Coagul Fibrinolysis; 1997 Sep; 8(6):345-9. PubMed ID: 9351524
[TBL] [Abstract][Full Text] [Related]
14. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
15. Protein C levels in disseminated intravascular coagulation and thrombotic thrombocytopenic purpura: its correlation with other coagulation parameters.
Takahashi H; Takakuwa E; Yoshino N; Hanano M; Shibata A
Thromb Haemost; 1985 Aug; 54(2):445-9. PubMed ID: 3841232
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Am J Hematol; 1991 Dec; 38(4):281-7. PubMed ID: 1660674
[TBL] [Abstract][Full Text] [Related]
17. Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator.
Takahashi H; Ito S; Hanano M; Wada K; Niwano H; Seki Y; Shibata A
Am J Hematol; 1992 Sep; 41(1):32-9. PubMed ID: 1323930
[TBL] [Abstract][Full Text] [Related]
18. Sepsis-induced disseminated intravascular coagulation with features of thrombotic thrombocytopenic purpura: a fatal fulminant syndrome.
Wang Z; Yu Z; Su J; Cao L; Zhao X; Ruan C
Clin Appl Thromb Hemost; 2011 Jun; 17(3):251-3. PubMed ID: 20211920
[TBL] [Abstract][Full Text] [Related]
19. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
Kotajima N; Kanda T; Fukumura Y; Kobayashi I
J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
[TBL] [Abstract][Full Text] [Related]
20. Recombinant thrombomodulin for secondary thrombotic thrombocytopenic purpura.
Nakamura K; Inokuchi R; Hiruma T; Ohshima K; Sonoo T; Tokunaga K; Doi K; Nakajima S
Medicine (Baltimore); 2016 Jun; 95(24):e3712. PubMed ID: 27310951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
